Effect of Cyclosporin A on the in Situ Inflammatory Response of Human Renal Allograft Rejection.

This publication has 9 references indexed in Scilit:

• IMMUNOLOGICAL AND PHARMACOLOGICAL MONITORING IN THE CLINICAL USE OF CYCLOSPORIN A
  The Lancet, 1981
• Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2
  European Journal of Immunology, 1981
• EFFECT OF CYCLOSPORIN-A ON INVITRO PROLIFERATIVE ACTIVITY AND IMMUNOGLOBULIN-SYNTHESIS OF ISOLATED HUMAN LYMPHOID-CELL SUB-POPULATIONS
  1981
• Monitoring of Human Renal Allograft Rejection with Fine‐needle Aspiration Cytology
  Scandinavian Journal of Immunology, 1981
• CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERS
  The Lancet, 1979
• TIMING OF CYCLOSPORIN-A THERAPY FOR ABROGATION OF HVG AND GVH RESPONSES IN RATS
  The Lancet, 1979
• CYCLOSPORIN A FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE IN MAN
  The Lancet, 1978
• CYCLOSPORIN A IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM CADAVER DONORS
  The Lancet, 1978
• Biological effects of cyclosporin A: A new antilymphocytic agent
  Inflammation Research, 1976